Missing Cheltenham teen with autism found, safely at home with family, police say
Emergency services called to serious collision on M5
Violence against Asian-Americans is appalling
Crash on I-85 SB ramp to I-65 cleared
FREE: Former classroom couches
Dock rebuild to boost access to historically rich Hassel Island
What number should be added to each of the three numbers -2, 5 and 20
WEST SEATTLE CRIME WATCH: Stolen red truck; more catalytic converters taken
Prince Philip’s lasting legacy – Channel 4 NewsChannel 4 NewsShare on FacebookShare on TwitterShare on WhatsAppShare on WhatsAppShare on WhatsAppLoad more share options
Climate Change and Wildlife Webinar
How can a student point out a faulty question
New Montrose Mayor Doug Glaspell aims for momentum, business development
HR 1 Will Make It ‘Easy to Vote and Easy to Cheat’
Bedtime With the Beatles Blue Cover (11 tracks)
Dr. Martin Elvis
Silver Spring Man Sentenced to 15 Years in Prison on Child Pornography Charges
Yes, job vacancies are high. But laziness is not the reason they aren’t being filled
COLUMN: Medicare volunteers provide critical service
Maya Jama under fire over short Prince Philip video clip taken outside Buckingham Palace
106-year-old woman gets her first Covid-19 vaccine jab in Bhopal
Religious leaders, others back gender policy review
Avance Clinical Client Atossa Therapeutics Announces Final Results From Phase 1 Clinical Study For AT-301 Nasal Spray

ADELAIDE, AU, Mar 12, 2021 - (ACN Newswire) - The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical congratulated Atossa Therapeutics on the announcement of their Phase 1 final results for the AT-301 nasal spray being developed for COVID-19.Yvonne Lungershausen, CEO, Avance Clinical said: "As the CRO for this important study, we congratulate Atossa Therapeutics on these impressive safety and tolerability clinical results.Australia's Avance Clinical has more than 20-years of experience and is now one of Australia's leading Contract Research Organizations.Avance Clinical facilitates quality drug development by aligning people, skills, and expertise in the pursuit of drug development for a healthier world.
Avance Clinical is committed to providing high-quality clinical research services with its highly-experienced team.The collective pool of knowledge and experience at Avance Clinical continually grows through the careful selection of experts who also demonstrate passion in their chosen field.